Honigman Miller Schwartz and Cohn LLP
09/17/2026 | Press release | Distributed by Public on 09/17/2026 07:54
Announcement | Sep 17, 2026Honigman Represents Catalio Capital Management as Lead Investor in Evvy’s $40 Million Series B Financing
Honigman recently represented Catalio Capital Management, a health care focused investment firm, as the lead investor in Evvy's $40 million Series B financing.
Evvy is a women's health platform that combines diagnostic testing, clinical insights, and care recommendations to help patients better understand and manage their health. The Company serves a broad patient base across the United States and works closely with health care providers.
The Honigman team was led by Corporate Partners Phillip D. Torrence and Rachel Rhodes with support from Associate Aaron Katz.
Honigman Miller Schwartz and Cohn LLP published this content on September 17, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 17, 2026 at 13:54 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]